BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nikokiraki C, Psaraki A, Roubelakis MG. The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases. Cells 2022;11:1410. [DOI: 10.3390/cells11091410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fengming Yi, Wei Zhang, Long Feng. Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis. World J Surg Oncol 2022;20:399. [PMID: 36527081 DOI: 10.1186/s12957-022-02867-w] [Reference Citation Analysis]
2 Chawla S, Das A. Preclinical-to-clinical innovations in stem cell therapies for liver regeneration. Curr Res Transl Med 2022;71:103365. [PMID: 36427419 DOI: 10.1016/j.retram.2022.103365] [Reference Citation Analysis]